Runzhou Ni

3.1k total citations
103 papers, 2.4k citations indexed

About

Runzhou Ni is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Runzhou Ni has authored 103 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 32 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Runzhou Ni's work include RNA modifications and cancer (17 papers), Cancer-related Molecular Pathways (16 papers) and Microtubule and mitosis dynamics (11 papers). Runzhou Ni is often cited by papers focused on RNA modifications and cancer (17 papers), Cancer-related Molecular Pathways (16 papers) and Microtubule and mitosis dynamics (11 papers). Runzhou Ni collaborates with scholars based in China, United States and Japan. Runzhou Ni's co-authors include Cuihua Lu, Mingbing Xiao, Feng Jiang, Wenkai Ni, Jinxia Liu, Lishuai Qu, Buyou Chen, Akira Ichihara, Yumiko Tomita and Kazunori Ishimura and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Oncogene.

In The Last Decade

Runzhou Ni

102 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runzhou Ni China 29 1.8k 711 436 417 274 103 2.4k
Mihai Gagea United States 27 1.6k 0.9× 784 1.1× 506 1.2× 363 0.9× 208 0.8× 62 2.4k
Maria Hatziapostolou United States 29 2.0k 1.2× 1.4k 2.0× 548 1.3× 461 1.1× 265 1.0× 52 3.2k
Manfred Jücker Germany 30 2.0k 1.1× 553 0.8× 904 2.1× 518 1.2× 177 0.6× 104 3.2k
Changcun Guo China 27 1.4k 0.8× 582 0.8× 451 1.0× 357 0.9× 299 1.1× 72 2.3k
Miguel Reina‐Campos United States 21 1.2k 0.7× 672 0.9× 628 1.4× 550 1.3× 395 1.4× 24 2.3k
Bo Tang China 28 1.8k 1.0× 932 1.3× 593 1.4× 639 1.5× 189 0.7× 70 2.9k
Luca Quagliata Switzerland 29 1.7k 1.0× 1.4k 1.9× 640 1.5× 446 1.1× 270 1.0× 73 2.9k
Jiong Bi China 27 1.7k 1.0× 1.0k 1.4× 594 1.4× 228 0.5× 135 0.5× 51 2.5k
Huamei Tang China 34 2.1k 1.2× 1.2k 1.7× 656 1.5× 232 0.6× 201 0.7× 83 2.9k
Qinong Ye China 31 2.1k 1.2× 1.2k 1.7× 536 1.2× 229 0.5× 203 0.7× 117 2.9k

Countries citing papers authored by Runzhou Ni

Since Specialization
Citations

This map shows the geographic impact of Runzhou Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runzhou Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runzhou Ni more than expected).

Fields of papers citing papers by Runzhou Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runzhou Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runzhou Ni. The network helps show where Runzhou Ni may publish in the future.

Co-authorship network of co-authors of Runzhou Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Runzhou Ni. A scholar is included among the top collaborators of Runzhou Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runzhou Ni. Runzhou Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, Jingxin Zhang, Shiqing Zhang, et al.. (2020). Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell International. 20(1). 28–28. 33 indexed citations
2.
Zhang, Susu, Jinxia Liu, Jing Zhu, et al.. (2019). Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis. Japanese Journal of Clinical Oncology. 49(7). 646–655. 12 indexed citations
3.
Chen, Xiaojun, Jie Ji, Rui Zhou, et al.. (2019). Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer. Genetic Testing and Molecular Biomarkers. 23(3). 215–222. 14 indexed citations
4.
Xiao, Mingbing, Dandan Jin, Wenkai Ni, et al.. (2018). β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway. Molecular Biology Reports. 45(6). 1863–1871. 18 indexed citations
5.
Huang, Hua, Mingbing Xiao, Feng Jiang, et al.. (2017). Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors. Experimental and Therapeutic Medicine. 14(2). 1749–1755. 2 indexed citations
6.
Yan, Lijun, Liang Wang, Jian’an Bai, et al.. (2017). Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn's disease. Clinics and Research in Hepatology and Gastroenterology. 41(4). 445–458. 4 indexed citations
7.
Zhang, Jianfeng, et al.. (2016). Enhanced expression of early mitotic inhibitor-1 predicts a poor prognosis in esophageal squamous cell carcinoma patients. Oncology Letters. 12(1). 114–120. 13 indexed citations
8.
Liu, Qingqing, Tao Tao, Fang Liu, et al.. (2016). Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma. Experimental Cell Research. 349(2). 230–238. 39 indexed citations
9.
Wang, Liang, Dongmei Zhang, Ji Qian, et al.. (2016). PRDM5 promotes the apoptosis of epithelial cells induced by IFN-γ during Crohn’s disease. Pathology - Research and Practice. 213(6). 666–673. 12 indexed citations
10.
Wang, Yayun, Liang Li, Jianguo Zhang, et al.. (2015). Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma. Tumor Biology. 36(11). 8735–8745. 8 indexed citations
11.
Zhang, Tingting, Xiubing Zhang, Weidong Shi, et al.. (2015). The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4. Pathology - Research and Practice. 212(3). 153–161. 14 indexed citations
12.
Zhang, Xiubing, Wenkai Ni, Weidong Shi, et al.. (2015). Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 61(3). 795–805. 23 indexed citations
13.
Hu, Baoying, Yan Xia, Fang Liu, et al.. (2015). Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression. Pathology & Oncology Research. 22(3). 555–565. 13 indexed citations
14.
Ni, Wenkai, Buyou Chen, Cuihua Lu, et al.. (2013). Overexpressed nuclear BAG‐1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin. Journal of Cellular Biochemistry. 114(9). 2120–2130. 19 indexed citations
15.
Wan, Chunhua, Shiqiang Hou, Runzhou Ni, et al.. (2013). MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene. 34(2). 237–245. 52 indexed citations
16.
Ni, Runzhou, Qingchun Deng, Xiaodong Huang, et al.. (2013). Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection. Pathobiology. 80(3). 155–162. 8 indexed citations
17.
Xiao, Mingbing, Runzhou Ni, Wenkai Ni, et al.. (2013). Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncology Letters. 6(4). 1152–1158. 28 indexed citations
18.
Lv, Liting, Qun Xue, Chunhua Wan, et al.. (2013). Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division. Molecular and Cellular Biochemistry. 381(1-2). 163–171. 26 indexed citations
19.
Liu, Zhaoxiu, Ravi P. Kiran, Ana E. Bennett, Runzhou Ni, & Bo Shen. (2011). Diagnosis and management of dysplasia and cancer of the ileal pouch in patients with underlying inflammatory bowel disease. Cancer. 117(14). 3081–3092. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihai Gagea Breakdown of academic impact, for papers by Maria Hatziapostolou Breakdown of academic impact, for papers by Manfred Jücker Breakdown of academic impact, for papers by Changcun Guo Breakdown of academic impact, for papers by Miguel Reina‐Campos Breakdown of academic impact, for papers by Bo Tang Breakdown of academic impact, for papers by Luca Quagliata Breakdown of academic impact, for papers by Jiong Bi Breakdown of academic impact, for papers by Huamei Tang Breakdown of academic impact, for papers by Qinong Ye
Rankless by CCL
2026